David Gillen is the Chief Medical Officer at Norgine, a seasoned pharmaceutical physician with deep expertise in oncology, hematology, and rare diseases. A graduate of Imperial College London, he has a demonstrated history of leadership in medical affairs and clinical development at companies like Vertex, Celgene, and Gilead, holding an FT Non-Executive Director certification.
David is a prominent voice in the pharmaceutical community, frequently participating in panels and summits. He contributes to discussions on the future of healthcare, from digital transformation in medical affairs to the critical importance of patient-centric approaches and preventative health strategies, sharing his insights from cross-sector collaborations.
He recently revitalized Norgines development department by restructuring the team, expanding medical affairs, and introducing a new patient advocacy department.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.